BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6242682)

  • 1. [Carbohydrate metabolism in normo- and hyperprolactinemic sterile patients and the possible treatment of sterility in juvenile diabetes mellitus with bromocriptine (Parlodel-Sandoz)].
    Alexander H; Ulrich FE; Herter U
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():118-24. PubMed ID: 6242682
    [No Abstract]   [Full Text] [Related]  

  • 2. [Carbohydrate metabolism in normo- and hyperprolactinemic sterility patients and the possible treatment of sterility in juvenile diabetes mellitus with bromocriptine (Parlodel-Sandoz)].
    Alexander H; Ulrich FE; Herter U
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():118-24. PubMed ID: 6211038
    [No Abstract]   [Full Text] [Related]  

  • 3. Experiences with the treatment of clinical hyperprolactinaemia.
    Nagy P; Szilágyi A; Csaba IF
    Zentralbl Gynakol; 1987; 109(12):788-94. PubMed ID: 3630462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic results in hyperprolactinemic sterility patients].
    Melzer H
    Zentralbl Gynakol; 1987; 109(8):517-20. PubMed ID: 3604494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sterility in hyperprolactinemic amenorrhea].
    Tscherne G; Urdl W
    Zentralbl Gynakol; 1983; 105(8):478-81. PubMed ID: 6868876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy rate following bromocriptine treatment in infertile women with galactorrhea.
    Eftekhari N; Mohammadalizadeh S
    Gynecol Endocrinol; 2009 Feb; 25(2):122-4. PubMed ID: 19253108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of treatment with bromoergocryptine in functional infertility caused by corpus luteum insufficiency].
    Apró G; Godó G; Sas M
    Zentralbl Gynakol; 1983; 105(8):473-7. PubMed ID: 6868875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperprolactinemic amenorrhea and sterility treated with bromocriptine].
    Polishuk WZ; Yarkoni S; Ben-David M; Spitz J
    Harefuah; 1975 Dec; 89(11):500-3. PubMed ID: 1205386
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-acting oral bromocriptine (Parlodel SRO) in the treatment of hyperprolactinemia.
    Weingrill CO; Mussio W; Moraes CR; Portes E; Castro RC; Lengyel AM
    Fertil Steril; 1992 Feb; 57(2):331-5. PubMed ID: 1735484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ
    Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of parlodel for the treatment of endocrine sterility in women with hyperprolactinemic amenorrhea].
    Persianinov LS; Pshenichnikova TIa; Manuilova IA; Sotnikova EI
    Akush Ginekol (Mosk); 1979 May; (5):21-3. PubMed ID: 474897
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience with the treatment of hyperprolactinemic conditions].
    Nagy P; Szilágyi A; Csaba I
    Orv Hetil; 1986 Mar; 127(10):573-6. PubMed ID: 3703537
    [No Abstract]   [Full Text] [Related]  

  • 13. Hachimijiogan treatment is effective in the management of infertile women with hyperprolactinemia or bromocriptine-resistant hyperprolactinemia.
    Usuki S; Usuki Y
    Am J Chin Med; 1989; 17(3-4):225-41. PubMed ID: 2633624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperprolactinemia and its effect on female sterility.
    Atasü T; Kösebay D; Arvas M
    Biol Res Pregnancy Perinatol; 1985; 6(3):133-6. PubMed ID: 3834948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Our experience in treating women with pathologic functional hyperprolactinemia and normal blood prolactin levels with bromocriptine].
    Markovski N; Ivanov S; Trepechev S; Spasiov S; Zhekova V
    Akush Ginekol (Sofiia); 1983; 22(6):417-22. PubMed ID: 6673607
    [No Abstract]   [Full Text] [Related]  

  • 16. A new oral slow release form of bromocriptine, Parlodel SRO, in the chronic treatment of 26 hyperprolactinemic patients.
    Gianola D; Pedroncelli A; Montini M; Tengattini F; Pagani MD; Cortesi L; Cappi MP; Gherardi F; Lancranjan I; Pagani G
    Gynecol Endocrinol; 1991 Sep; 5(3):213-6. PubMed ID: 1776507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Outcome of parlodel treatment in women with hyperprolactinemia].
    Pakhomova IA; Manuilova IA; Afonina LI; Nazarenko TA
    Akush Ginekol (Mosk); 1984 May; (5):8-11. PubMed ID: 6465465
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience obtained from prolactin-inhibiting therapy for functional sterility (author's transl)].
    Gazárek F; Zenisek L; Talas M; Stehliková J; Fingerová H
    Zentralbl Gynakol; 1980; 102(20):1145-7. PubMed ID: 7211013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin levels in infertility and bromocriptine therapy in hyperprolactinaemia.
    Prathibha D; Govardhani M; Krishna PT
    J Indian Med Assoc; 1994 Dec; 92(12):397-9. PubMed ID: 7876578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy, tolerability and safety of Parlodel LAR versus Parlodel in hyperprolactinemia.
    Bolanowski M; Milewicz A; Bohdanowicz-Pawlak A; Bednarek-Tupikowska G; Jedrzejak JA; Lancranjan I
    Endokrynol Pol; 1993; 44(4):467-76. PubMed ID: 8055815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.